Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Comprehensive Income (Loss)

v3.23.1
Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]      
Revenues $ 299 $ 15,641 $ 6,137
Cost of revenues 400 2,005 3,002
Gross Profit (loss) (101) 13,636 3,135
Operating expenses:      
Research and development 10,255 7,631 4,065
General, administrative and marketing 6,741 5,940 4,669
Total operating income (loss) (17,097) 65 (5,599)
Financial income (expenses), net 172 172 (175)
Net income (loss) $ (16,925) $ 237 $ (5,774)
Basic net income (loss) per ordinary share (in Dollars per share) $ (1.53) $ 0.02 $ (0.84)
Diluted net income (loss) per ordinary share (in Dollars per share) $ (1.53) $ 0.02 $ (0.84)
Weighted average ordinary shares outstanding used in computation of basic net income (loss) per share (in Shares) 11,033,310 9,968,972 6,886,955
Weighted average ordinary shares outstanding used in computation of diluted net income (loss) per share (in Shares) 11,033,310 11,966,788 6,886,955